Transcriptional regulation of interleukin‐2 gene expression by CD69‐generated signals
- 1 November 1993
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (11) , 2993-2997
- https://doi.org/10.1002/eji.1830231140
Abstract
The 5′ flanking region of the human interleukin (IL)‐2 gene was investigated for enhancer activity in response to CD69‐generated signals, using a chloramphenicol acetyltransferase (CAT)‐driven transient expression system in Jurkat cells. The region extending from −317 to +47 relative to the initiation site of IL‐2 gene transcription was shown to contain sequences able to respond to CD69 cross‐linking, by enhancing by about 100 % a phorbol 12‐myristate 13‐acetate (PMA)‐plus‐ionomycin stimulation of CAT activity. A similar increase in CAT activity produced by PMA‐plus‐anti‐CD3 mAb was induced by CD69 cross‐linking, while a 200 % increase over that obtained by PMA‐plus‐anti‐CD28 mAb stimulation was seen. Analysis of enhancer deletion mutants revealed that proximal AP‐1, OCT‐1/octamer‐associated protein and nuclear factor of activated T cells (NFAT) binding regions were all necessary to allow CD69‐mediated enhancement of CAT activity. By gel mobility shift analysis, cyclosporin A‐sensitive NFAT‐binding induction and enhancement of AP‐1 binding activity could be detected in nuclear extracts of both Jurkat and peripheral blood T cells after simultaneous CD69 and protein kinase C stimulation. Finally, CD69‐mediated signals could increase NFAT and AP‐1 binding activity following PMA and ionomycin stimulation in peripheral blood T cells. Collectively, these data suggest that CD69‐generated signals participate in the control of the IL‐2 gene expression at the transcriptional level, likely acting through NFAT and AP‐1 transcription factor complexes.Keywords
This publication has 29 references indexed in Scilit:
- Tumor necrosis factor‐α production induced in T lymphocytes through the AIM/CD69 activation pathwayEuropean Journal of Immunology, 1992
- CD69, An Early Activation Antigen on Lymphocytes, Is Constitutively Expressed by Human Epidermal Langerhans CellsJournal of Investigative Dermatology, 1992
- The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.The Journal of Experimental Medicine, 1992
- Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28Science, 1991
- Transmission of Signals from the T Lymphocyte Antigen Receptor to the Genes Responsible for Cell Proliferation and Immune Function: The Missing LinkAnnual Review of Immunology, 1990
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989
- Human T cell activation. IV. T cell activation and proliferation via the early activation antigen EA 1.The Journal of Experimental Medicine, 1989
- Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.The Journal of Experimental Medicine, 1988
- Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen.The Journal of Experimental Medicine, 1988
- Regulation of human interleukin-2 gene: Functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytesCell, 1986